RxDoctor Payments Data

Taja Elder, NP

Nurse Practitioner · Dublin, OHNPI 1053894121

Payments from drug & device makers

$2,803in general payments, 2019–2025

Across 118 payments — averaging $23.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$768
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$740
  • Saluda Medical Americas, Inc.$339
  • GRT US Holding, Inc.$154
  • Scilex Pharmaceuticals Inc.$153
  • Boston Scientific$129
  • plus $519 from 12 others

What the payments were for

  • Food & beverage$2,803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,803 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$7,566
Medicare patients
51
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide28$65,447
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,294$55,122
Pregabalin330$19,673
Gabapentin1,400$14,553
Lidocaine55$3,940
Ondansetron Hcl20$1,184
Tramadol Hcl83$957
Tizanidine Hcl149$853
Naloxone Hcl11$672
Diclofenac Sodium50$598
Cyclobenzaprine Hcl91$554
Baclofen35$520
Duloxetine Hcl55$510
Amitriptyline Hcl57$318
Celecoxib13$300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$740$65,44728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →